studies on glp 1 Real-World Evidence for GLP-1 Receptor Agonists Across the CKD Spectrum – AJKD Blog Clinical efficacy results from clinical
Description
When estimated for CKD populations, GLP-1RAs were associated with $673 cost savings compared with long-acting insulin and an ICER of $1675 per QALY gained
The primary concern is absorption timing, not a chemical interaction between the drugs
Lopez, Pedro, et al
Enhanced Metabolic Health In addition to weight loss, GLP-1 medications can lead to improvements in metabolic health markers, such as blood sugar levels, cholesterol, and blood pressure
These appetite-suppressing effects have contributed to the increasing use of GLP-1RAs in obesity management [57,58]
For weight loss, most plans require documentation of at least three to six months of lifestyle changes, such as changes in nutrition and exercise
